About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Multiple Sclerosis Drug, Techfidera, from Biogen Has Been Approved by FDA

by Raja Nandhini on March 29, 2013 at 6:56 AM
 Multiple Sclerosis Drug, Techfidera, from Biogen Has Been Approved by FDA

FDA has given its green signal for the new drug, Techfidera from Biogen, to treat multiple sclerosis. Multiple sclerosis is an autoimmune disorder causing difficulty in walking, vision and thinking, and has affected more than two million people worldwide.

Dimethyl fumarate is the chemical name of the drug and it is the compound previously used in Europe to protect shoes and sofas from moulds. But following reports of skin allergy the chemical was banned in Europe.

Advertisement

The drug had produced remarkable results in clinical trials and had cut down the relapse rate by nearly 49%. Moreover, the side effects if the drug seemed to be minimal when compared to other treatment options currently available. Side effects include flushing, diarrhea and nausea.

FDA has recommended testing white blood cell count once in every year after commencing the treatment.

This promising drug, which is available in a convenient pill form, is expected to hit the market very soon. The approval has hiked the share value of Biogen Idec Inc by 3.2%.

Source: Medindia
Font : A-A+

Advertisement

Advertisement
Advertisement

Recommended Readings

Latest Drug News

Promising ALS Drug Candidate Extends Lifespan
The study explores whether CDNF could influence the progression of ALS in rodent models and to elucidate the mechanism through which it operates.
Amoxicillin-Calvulanate Vs Amoxicillin Preference in Child Sinusitis Treatment
Amoxicillin-clavulanate use in acute sinusitis patients is associated with a higher incidence of adverse events.
ADHD Medication Errors Surge by Nearly 300%
Professionals advocate for enhanced education of patients and caregivers, and creation of more effective child-resistant systems for monitoring ADHD medication.
Unknown Medication Side Effects Reported by 52% of Indian Families
In June, WHO raised concerns about 7 Indian cough syrups after complaints from several countries about contamination and health issues.
Painkillers With Hormonal Contraception Linked to Blood Clot Risk
Women using hormonal contraception, along with their healthcare providers, should explore alternative pain relief options instead of NSAIDs.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
MediBotMediBot
Greetings! How can I assist you?MediBot
×

Multiple Sclerosis Drug, Techfidera, from Biogen Has Been Approved by FDA Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests